ArticleChina CDC weekly2025
Epidemiological and Population Characteristics of Seroprevalence of TTIs Among Voluntary Blood Donors - Guangzhou City, Guangdong Province, China, 2014-2023.
Article in China CDC weekly, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prevalence of anti-HBc and anti-HBs among blood donors in Guangzhou: implications for HBV screening strategies in China.BMC infectious diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Transfusion-transmitted infections (TTIs) pose significant public health challenges. Screening potential blood donors for hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and Treponema pallidum (TP), along with ongoing monitoring of epidemiological data on TTIs among donors, is essential to ensure blood safety. Methods: This study conducted a retrospective analysis of the seroprevalence of HBsAg, anti-HCV, anti-HIV, and anti-TP among 3,111,265 blood donation events in Guangzhou from 2014 to 2023, investigating their relationships with demographic characteristics such as gender, age, and donation status. Results: The findings indicated that the overall seroprevalence of TTIs among blood donations was 866.21 per 100,000, demonstrating a declining trend over the ten-year period. Seroprevalence rates of transfusion-transmissible infections also exhibited a downward trend across various demographic groups. Notably, male donors, first-time donors, and older donors demonstrated higher seroprevalence rates for TTIs. Conclusions: While the overall seroprevalence rate of transfusion-transmissible infections among blood donors remains relatively low, significant disparities exist among different demographic groups. It is necessary of sustained TTIs monitoring among blood donors to guide public health interventions and donor screening practices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.